Full Text View
Tabular View
No Study Results Posted
Related Studies
High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
This study has been completed.
Study NCT00513396   Information provided by GSVM Medical College
First Received: August 6, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculosis, Multidrug-Resistant
Additional conditions recognized in this trial
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections
Interventions listed in this trial
Isoniazid
Placebo
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antilipemic Agents
Antimetabolites
Antitubercular Agents
Fatty Acid Synthesis Inhibitors
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
GSVM Medical College


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services